Shorter Radiation Course Recommended for Breast Cancer Treatment
By MedImaging International staff writers Posted on 29 Jun 2016 |
Image: A shorter radiation course is recommended for early-stage breast cancer patients (Photo courtesy of the University of Texas MD Anderson Cancer Center).
A new study suggests that early-stage breast cancer (BC) patients who receive shorter radiation therapy (RT) treatments with higher doses per fraction show cosmetic, functional, and pain outcomes similar to those receiving a conventional longer, lower-dose per fraction courses of treatment.
Researchers at the University of Texas MD Anderson Cancer Center (Houston, USA) conducted a study involving 287 women with stage 0 to stage II BC, who were randomized to receive conventionally fractionated whole-breast irradiation (CF-WBI, 149 patients) or hypo-fractionated whole-breast irradiation (HF-WBI, 138 patients) following breast-conserving surgery between 2011 and 2014. Longitudinal patient-reported outcomes and physician-rated cosmesis were assessed at 0.5, 1, 2, and 3 years after RT.
The results showed that patient-reported functional status and breast pain improved significantly following both radiation schedules, and there were no significant differences in physician-reported cosmetic evaluations at any time point. In a previously published study, the authors showed that patients receiving HF-WBI experienced less acute toxicity and post-radiation fatigue compared to those treated with CF-WBI. The study was published on June 15, 2016, in Cancer.
“This trial is particularly important, because there is still some hesitation among clinicians in the U.S. about adopting the hypofractionated schedule,” said lead author Cameron Swanick, MD. “Because American patients tend to have a higher prevalence of obesity, and because prior trials excluded certain patients with high body mass index, there has been this concern that the shorter radiation treatment course may not be as safe for American patients.”
“The results of this and previous studies further support the use of HF-WBI as the preferred radiation therapy for early-stage breast cancer patients; at MD Anderson these shorter courses have become the standard of care,” said study co-author Benjamin Smith, MD, an associate professor of radiation oncology. “This was the first investigator-initiated randomized trial conducted in the network. It was a success because of the support of our partners and illustrated the potential, promise and power of our network to help achieve our mission.”
Related Links:
University of Texas MD Anderson Cancer Center
Researchers at the University of Texas MD Anderson Cancer Center (Houston, USA) conducted a study involving 287 women with stage 0 to stage II BC, who were randomized to receive conventionally fractionated whole-breast irradiation (CF-WBI, 149 patients) or hypo-fractionated whole-breast irradiation (HF-WBI, 138 patients) following breast-conserving surgery between 2011 and 2014. Longitudinal patient-reported outcomes and physician-rated cosmesis were assessed at 0.5, 1, 2, and 3 years after RT.
The results showed that patient-reported functional status and breast pain improved significantly following both radiation schedules, and there were no significant differences in physician-reported cosmetic evaluations at any time point. In a previously published study, the authors showed that patients receiving HF-WBI experienced less acute toxicity and post-radiation fatigue compared to those treated with CF-WBI. The study was published on June 15, 2016, in Cancer.
“This trial is particularly important, because there is still some hesitation among clinicians in the U.S. about adopting the hypofractionated schedule,” said lead author Cameron Swanick, MD. “Because American patients tend to have a higher prevalence of obesity, and because prior trials excluded certain patients with high body mass index, there has been this concern that the shorter radiation treatment course may not be as safe for American patients.”
“The results of this and previous studies further support the use of HF-WBI as the preferred radiation therapy for early-stage breast cancer patients; at MD Anderson these shorter courses have become the standard of care,” said study co-author Benjamin Smith, MD, an associate professor of radiation oncology. “This was the first investigator-initiated randomized trial conducted in the network. It was a success because of the support of our partners and illustrated the potential, promise and power of our network to help achieve our mission.”
Related Links:
University of Texas MD Anderson Cancer Center
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection